Assessing the association of appropriateness of coronary revascularization and 1-year clinical outcomes for patients with stable coronary artery disease in China.

CONCLUSIONS: In patients with appropriate indications according to Chinese AUC, coronary revascularization was associated with significantly lower risk of MACCEs at 1 year. No benefit was found in coronary revascularization in patients with inappropriate indications. Our findings provide evidence for using Chinese AUC to guide clinical decision-making.
CLINICAL TRIAL REGISTRATION: NCT02880605. https://www.clinicaltrials.gov.
PMID: 31923098 [PubMed - in process]

Source: Chinese Medical Journal - January 4, 2020 Category: General Medicine Authors: Lin S, Zhang H, Rao CF, Chen SP, Qiao SB, Yan HB, Dou KF, Wu YJ, Tang YD, Yang XC, Shen ZJ, Liu J, Zheng Z, Beijing Coronary Angiography Registry Collaborative Group Tags: Chin Med J (Engl) Source Type: research